Number of the records: 1
leukotriény
SYS d015289 LBL 00000cz--a2200000n--4500 005 20250606214251.3 008 920524|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D10.251.355.255.100.450 065 $a D10.251.355.310.166.887 065 $a D23.469.050.175.450 066 $a 01 $c 03 150 $a leukotriény $x AD $x AE $x AG $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Leukotriene $2 eng 450 $w v $a leukotrién $2 slo 550 $7 sllk_us_auth*d018077 $Y Receptors, Leukotriene $w p $a receptory leukotriénové 665 $a 89 $2 eng 665 $a Arachidonic Acids (1979-1988) $2 eng 665 $a Leukotrienes B (1983-1988) $2 eng 665 $a SRS-A (1979-1988) $2 eng 680 9-
$i A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system. $2 eng 680 $a general or unspecified; prefer specifics $2 eng 750 -2
$a Leukotrienes $2 eng 980 $x M
Number of the records: 1